DearDoc already reaches 1,000+ clinics and 100,000+ patients
1,000+
Clinics
100,000+
Patients
A practice growth and patient engagement platform: AI chat, automated reviews, online scheduling, websites.
That reach is the asset. How much more value can it carry?
The opportunity
Clinic spend happens outside the platform today
Spend already exists
Clinics already pay for specialty products, wellness testing, advertising, and payment processing.
DearDoc sees none of it
DearDoc earns none of that revenue, and each outside vendor pulls clinic attention away.
Bring it inside
Bringing these services inside DearDoc turns existing clinic spend into new platform revenue.
Three winners
DearDoc
Residual revenue on every partner service, deeper retention, a stronger valuation story.
Clinics
New revenue lines and non-public pricing, with nothing to build.
Patients
More of their care in one place they already trust.
Silent Nexus is the single connecting point
One partner, one set of terms, a network of established specialist operators.
Our clinic network
Clinics we will introduce to DearDoc
Referral partners
Partners who send clinics our way
Advertising for DearDoc
CTV campaigns to grow DearDoc's own clinic base
The network rolls out in three waves
Wave 1 · Launch first
- Peptide fulfillment via licensed 503A/503B pharmacies
- Genetic wellness testing with personalized supplements
- Direct-to-consumer genetic testing for DearDoc patients
Wave 2 · Next
- CTV advertising
- Payments and patient financing
- Reporting, financial visibility, and creative
Later wave
- Telemedicine for DearDoc's patients
01
Wave 1: peptides and genetic testing
Peptides
$2,000
A year per clinic for DearDoc, conservatively
Clinics order through the network. Licensed 503A and 503B pharmacies fulfill. Silent Nexus never handles product. Clinics set their own patient pricing.
Peptide math per clinic
Step | Amount |
|---|---|
Clinic orders per month (very low average) | $5,000 |
Product cost, at an illustrative 20% markup | $4,167 |
Net profit | $833 |
DearDoc's share, 20% of net | $167 a month |
Per year | $2,000 |
Illustrative and conservative; margins vary by compound, batch, and other factors.
Genetic testing opens an ongoing wellness relationship
At-home cheek swab
39 genes, 49 markers, $299 patient price. AI guidance explains results in plain language.
Personalized supplement plan
Patients reorder monthly. Also: pharmacogenomics and GLP-1 genetics, all 50 states.
Nothing to build
CLIA-certified, CAP-accredited lab ships kits and returns reports. Direct API, co-branded SSO portal, or website widget; HIPAA aligned with a signed BAA.
Who earns
DearDoc: 10% of gross supplement sales; no per-test commission, per anti-kickback rules. Clinics: 20% of supplement sales, plus wholesale test resale margin where state law permits.
Supplement reorders compound DearDoc's testing revenue
DearDoc's 10% of supplement sales | Conservative | Partner's standard example |
|---|---|---|
Month 12, per month | $7,320 | $154,320 |
Year 1 total | $37,695 | $890,060 |
Run rate entering Year 2 | $87,840 a year | $1,851,840 a year |
Conservative case
10 clinics growing to 100 by Month 12, 100 patients per clinic, participation 5% rising to 20%, half on supplements, $150 average monthly order.
Partner's standard example
The same 100 clinics with 500 patients each, participation rising to 40%, 75% on supplements.
Illustrative, from the partner's calculator. No commission on tests. Not a guarantee. Genetic associations are not diagnoses.
Direct to patient
30%
Of gross supplement sales, with no clinic in the middle
DearDoc's 100,000+ patients are a second market; direct-to-consumer testing launches in Wave 1. Telemedicine follows in a later wave.
Direct-to-patient testing pays DearDoc three times the clinic rate
Patients on supplements by Month 12 | DearDoc per month at Month 12 | DearDoc Year 1 | Run rate entering Year 2 |
|---|---|---|---|
1,000 (1% of patients), $150 order | $45,000 | $321,930 | $540,000 a year |
10,000 (10% of patients), $200 order | $600,000 | $4,130,760 | $7,200,000 a year |
From the partner's DTC calculator. No commission on tests. Illustrative, not a guarantee. Proposed terms, final structure set with counsel.
02
Wave 2: advertising, payments, reporting
CTV advertising earns DearDoc $3,000 a year per clinic at the low end
- Streaming TV ads built for clinics, at rates most advertisers can't get even buying direct, via major DSP relationships
- Premium audience data; self-serve or full service, including creative, or clinics upload their own
- Brand campaigns fit any clinic; medicine advertising follows LegitScript certification, exceptions reviewed case by case
Larger clinics spend $100,000+ a month, putting DearDoc at $2,500 a month from one clinic.
$3,000
Step | Amount |
|---|---|
Monthly spend (lowest end) | $10,000 |
Agency profit at 25% | $2,500 |
DearDoc's share, 10% of net | $250 a month |
Per year | $3,000 |
DearDoc Payments: a stronger stack with built-in financing
Every way to pay
Visa, Mastercard, Amex, Discover, Apple Pay, Google Pay, Tap to Pay on iPhone and Android. Lower-cost bank payments verified through Plaid; invoices and payment links.
Patient financing up to $25,000
Over 3 to 60 months; clinic paid in full same or next business day, no clinic fee. Compliance handled: PCI DSS Level 1, network tokens, 3D Secure 2.0, underwriting, KYC, monitoring.
Typical processing providers cost, per year
$39K–$45K
With us, per year
$19,500
Fees for a clinic financing $50,000 a month. DearDoc earns a pre-agreed residual split; share your processing volume and we'll model the exact number together.
Financing subject to credit approval; powered by Flex Pay; fee comparison from partner estimates, October 2026.
Draft, to be finalized with our partner
Reporting gives full financial visibility into every clinic
Every channel
Reporting and tracking across every channel.
All money in and out
Organization- and clinic-level visibility.
Creative
Campaigns and brand; web, SEO, and marketing that add to DearDoc's tools.
Pricing and residuals
Clinics get non-public pricing; DearDoc and Silent Nexus earn residuals.
Every service pays three pockets
Service | DearDoc | Clinic | Silent Nexus |
|---|---|---|---|
Peptides | 20% of net profit | Sets own patient pricing and keeps 100% of their markup. | 80% of net profit |
Genetic testing | 10% of supplement sales | 20% of supplement sales, plus test resale margin where state law permits | 5% (partner 5%) |
Direct-to-consumer testing | 30% of supplement sales | n/a | 5% (partner 5%) |
CTV advertising | 10% of net profit | Rates they can't get alone | 10% of net profit |
Payments | Pre-agreed residual split | Better stack, financing, lower fees | Residual split |
Reporting and visibility | Residuals | Preferred pricing | Residuals |
Proposed terms; final structure set with counsel as a partner program.
Up to $5.4M for DearDoc in Year 1, before payments and DTC
Each participating clinic uses peptides, genetic testing, and CTV at low-end assumptions; genetic testing stays low because Year 1 is mostly ramp-up. Excludes payments, reporting, and direct-to-consumer testing. Illustrative, not a guarantee.
Clinics | Total |
|---|---|
10 | $53,770 |
25 | $134,424 |
50 | $268,848 |
100 | $537,695 |
500 | $2,688,475 |
1,000 | $5,376,950 |
Launch with a pilot, then expand
Wave 1 pilot
Peptides and genetic testing, for clinics and direct to patients; pilot 10 to 25 clinics to confirm ordering, fulfillment, tracking, reporting.
Expand
To 50 to 100 active clinics once the pilot proves out.
Wave 2
CTV, payments, and reporting on DearDoc's schedule.
Later
Telemedicine.
Or launch everything at once if DearDoc prefers.
Approve Wave 1 and set a working session
Approve Wave 1, launching partner by partner, starting with peptides and genetic testing.
Set a working session to finalize terms and the integration path, with counsel on both sides.
Next steps
- Agree on Wave 1 in principle
- Working session: terms, integration path, pilot clinic list
- Counsel finalizes the partner program structure
- Pilot clinics go live
We're ready to start immediately once the partnership is agreed.
Appendix
How integration works
Peptides
Clinics order through the network, licensed pharmacies fulfill, Silent Nexus coordinates and tracks.
Genetic testing
Direct API (orders, results, supplement subscriptions inside DearDoc), co-branded portal with Google or Microsoft 365 sign-in, or website widget; unique clinic IDs, webhooks, audit logs.
CTV
Self-serve signup and launch, or full service.
Payments
One integration with embedded checkout, APIs, and onboarding support; each clinic applies once.
Appendix
Compliance posture
Peptides fulfilled only by licensed 503A and 503B pharmacies; Silent Nexus never handles product.
Lab is CLIA-certified and CAP-accredited; HIPAA aligned with a signed BAA; access scoped per organization; genetic associations are not diagnoses.
CTV follows LegitScript certification wherever medicine is advertised.
Payments are PCI DSS Level 1 with underwriting, KYC, and monitoring for every clinic.
All revenue sharing structured with counsel as a partner program.
Partnership proposal
A proposal from Silent Nexus Holdings, prepared for DearDoc leadership, October 2026